EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Design and Development of Novel Glitazones for Activation of PGC-1α Signaling Via PPAR-γ Agonism: A Promising Therapeutic Approach against Parkinson’s Disease

Prabitha Prabhakaran, Abhishek Nadig, Sahyadri M, Sunanda Tuladhar, Ruby Mariam Raju, Saravana Babu Chidambaram, Bettadaiah Bheemanakere Kempaiah, Nulgumnalli Manjunathaiah Raghavendra iD, Prashantha Kumar Br iD

ACS Omega · 21.02.2023 · 8 (7) · 6825-6837

DOI: 10.1021/acsomega.2c07521 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Omega, online erschienen am 10.02.2023. Verfasst von Prabitha Prabhakaran und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru 570 015, Karnataka, India. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru 570 015, Karnataka, India.
  • Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru 570 015, Karnataka, India.
  • Spice and Flavour Science Department, CSIR-Central Food Technological Research Institute, Mysore 570 020, Karnataka, India.
  • Department of Pharmaceutical Sciences, Dayananda Sagar University, Bengaluru 560 078, Karnataka, India.

ORCID-Profile: Nulgumnalli Manjunathaiah Raghavendra, Prashantha Kumar Br

Förderung

  • Department of Science and Technology, Ministry of Science and Technology, India

Zitieren

APA

Prabhakaran, P., Nadig, A., M, S., Tuladhar, S., Raju, R. M., Chidambaram, S. B., Kempaiah, B. B., Raghavendra, N. M., & Kumar Br, P. (2023). Design and Development of Novel Glitazones for Activation of PGC-1α Signaling Via PPAR-γ Agonism: A Promising Therapeutic Approach against Parkinson’s Disease. ACS Omega, 8(7), 6825-6837. https://doi.org/10.1021/acsomega.2c07521

Vancouver

Prabhakaran P, Nadig A, M S, Tuladhar S, Raju RM, Chidambaram SB, et al. Design and Development of Novel Glitazones for Activation of PGC-1α Signaling Via PPAR-γ Agonism: A Promising Therapeutic Approach against Parkinson’s Disease. ACS Omega. 2023;8(7):6825-6837. doi:10.1021/acsomega.2c07521

BibTeX
@article{Prabhakaran2023,
  author = {Prabhakaran, Prabitha and Nadig, Abhishek and M, Sahyadri and Tuladhar, Sunanda and Raju, Ruby Mariam and Chidambaram, Saravana Babu and Kempaiah, Bettadaiah Bheemanakere and Raghavendra, Nulgumnalli Manjunathaiah and Kumar Br, Prashantha},
  title = {Design and Development of Novel Glitazones for Activation of PGC-1α Signaling Via PPAR-γ Agonism: A Promising Therapeutic Approach against Parkinson’s Disease},
  journal = {ACS Omega},
  year = {2023},
  volume = {8},
  number = {7},
  pages = {6825--6837},
  doi = {10.1021/acsomega.2c07521}
}
Kostenlos starten →